Company Profile

Hainan Poly Pharm Co., Ltd
Year Established : 1992
Total Assets(USD) : choose not to disclose
Total Number of Staff : 450 to 499
Main Competitive Advantages : International Approvals/Standards,Experienced R&D Staff,Production capacity,Contract Manufacturing,Small Orders Accepted
Other Competitive Advantages : You can find a good partner here: - Qualified injectable supplier for USA / EU/ WHO market - Contract manufacturing of sterile injectable products - R&D service for both injectable and ER products - Expanding your products to Chinese market
Patents and Copyrights : Many Patents!
  • Contact Person :
  • Fax:

Hainan Poly Pharm, a leading pharmaceutical manufacturer in China, was founded in 1992. We are specializing in injection and solid formulation. Our mission is to supply special finished products worldwide with good quality and competitive price.

One of our manufacturing facilities is located in Haikou, which received GMP certificate by CFDA (China) in 2002. Poly Pharm became one of few injectable manufacturers in China who successfully passed the WHO GMP and EU GMP inspection for both API and injection lines in 2012. The API and injection lines are all inspected by US FDA in Jan. 2014. The other facility will be constructed and put into operation before 2016 in Hangzhou.

Zhejiang Poly Pharm, Poly Pharm Group’s subsidiary, is located in Hangzhou. It was a domestic distributor which complianced with GSP. It maintains more than 30% sales growth rate for 3 years and established good relationship with more than 800 medicine commercial companies, 1500 hospitals and 5000 pharmacy shops in domestic market.

Hangzhou Sharply Research and Development Co. Ltd, Poly Pharm Group’s another subsidiary for registration and R&D, focus on formulation development including controlled release formulations, suspensions and injections. It has more than 26 patents for the products. It also offers contract development for some other pharmaceutical companies.